* Businesses want elderly to be part of first phase vaccination
* Business body says third wave could overwhelm health workers
* Govt vaccinated 13% of the targeted 1.25 mln under phase I
By Promit Mukherjee
JOHANNESBURG, March 22 (Reuters) – A South African business lobby group called on Monday for the government to shift the emphasis on its vaccine programme to target the elderly and vulnerable sooner, to prevent hospitals being overrun in a third wave of COVID-19 infections.
South Africa is behind schedule in the first phase of its vaccination programme, aimed at inoculating health care workers. Those over 60 or with co-morbidities are not meant to be vaccinated until a later second phase, along with other essential workers and people who work in crowded settings.
Stavros Nicolaou, an executive of Aspen Pharmacare which has a contract to make Johnson & Johnson COVID-19 vaccines in South Africa, and who also serves as chairman of the Public Health Workgroup at business lobby Business for South Africa (B4SA), said the group had called for changes in light of the slow rollout.
The lobby group had written to the government this month, recommending elderly and vulnerable people be moved higher up the priority list, he said.
“In the absence of having sufficient vaccines in quarter two, it makes more sense to start vaccinating people who are in the mortality curve, and not overwhelm the healthcare services,” Nicolaou told Reuters on Monday.
South Africa’s vaccination campaign was slowed after it cancelled the use of AstraZeneca vaccines, found in a small study to be less effective against a variant of the coronavirus dominant in the country.
So far only 160,000 health workers have been vaccinated with Johnson & Johnson’s COVID-19 vaccine, just 13% of the target to vaccinate 1.25 million people by the end of first quarter.
An email sent to the government was not immediately answered. March 22 is a public holiday in South Africa. (Reporting by Promit Mukherjee Editing by Peter Graff)
(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html
